The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors.
Maram AlShammariGhadah Asaad AssiriMohammed Bin BuraykanYasser S AlmogbelAzher ArafahAdel S BashatahYazed Sulaiman H Al-RuthiaPublished in: Patient preference and adherence (2020)
DTCA of OTC drugs for GERD, particularly if the content complies with the regulatory requirements, can promote the public knowledge of the disease and treatment options.